Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

EBS Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: May 04, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Emergent BioSolutions Inc (EBS)

Based on 6 analysts giving stock ratings to Emergent BioSolutions Inc in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
17
Buy
66
Hold
17
Sell
0
Strong Sell
0
Emergent BioSolutions Inc

Emergent BioSolutions Inc. Stock Analysis EBS

United States Health Care Small Cap Report:
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. The company is headquartered in Gaithersburg, Maryland and currently employs 900 full-time employees. The company went IPO on 2006-11-15. The company is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.
Read More

Emergent BioSolutions Inc (EBS) Chart

Key Statistics of Emergent BioSolutions Inc (EBS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$7.80$8.07

Today's Open

$7.80

Volume

838.72K

P/E Ratio (TTM)

7.75

52 Week Range

$5.62$14.06

Market Cap

431.86M

Avg. Volume

972.44K

Dividend Yield

-

Financial Metrics & Statements of Emergent BioSolutions Inc (EBS)

FAQ's for Emergent BioSolutions Inc (EBS)

  • According to Musaffa’s Shariah screening methodology, Emergent BioSolutions Inc (EBS) is currently classified as NOT HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Emergent BioSolutions Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Emergent BioSolutions Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Emergent BioSolutions Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Emergent BioSolutions Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Emergent BioSolutions Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.